|
End-of-day quote
LUXEMBOURG S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 40.20 USD | -1.47% |
|
+0.50% | +33.11% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 45.94B | B | ||||||||
| 37.22B | A | ||||||||
| 12.06B | BB | ||||||||
| 11.74B | A | ||||||||
| 9.03B | - | ||||||||
| 7.36B | A | ||||||||
| 7.2B | BB | ||||||||
| 7.15B | AA | ||||||||
| 5.03B | - | BB | - | - | - | ||||
| 4.64B | BB | ||||||||
| 4.24B | A | ||||||||
| 3.66B | A | ||||||||
| 3.53B | - | BB | - | - | - | - | - | ||
| 2.85B | B | ||||||||
| 2.69B | - | CCC | - | - | - | - | - | ||
| 2.67B | - | B | - | - | - | - | |||
| 2.52B | B | ||||||||
| 2.3B | - | - | - | - | - | ||||
| 2.26B | - | - | - | - | - | - | |||
| Average | 9.16B | BBB | |||||||
| Weighted average by Cap. | BBB |
- Stock Market
- Stocks
- RICHTER Stock
- CHWGR Stock
- Sector Gedeon Richter
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
















